INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 155 filers reported holding INARI MED INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,421,691 | +8.2% | 98,191 | -3.8% | 0.04% | +16.7% |
| Q2 2023 | $5,936,385 | -1.2% | 102,105 | +4.9% | 0.04% | -7.7% |
| Q1 2023 | $6,007,734 | -3.1% | 97,307 | -0.2% | 0.04% | -9.3% |
| Q4 2022 | $6,199,070 | -13.1% | 97,531 | -0.7% | 0.04% | -17.3% |
| Q3 2022 | $7,135,000 | +33.8% | 98,230 | +25.3% | 0.05% | +44.4% |
| Q2 2022 | $5,331,000 | +244.2% | 78,402 | +358.8% | 0.04% | +350.0% |
| Q1 2022 | $1,549,000 | -7.2% | 17,089 | -6.6% | 0.01% | 0.0% |
| Q4 2021 | $1,669,000 | +10.6% | 18,291 | -1.7% | 0.01% | 0.0% |
| Q3 2021 | $1,509,000 | -15.1% | 18,606 | -2.3% | 0.01% | +33.3% |
| Q2 2021 | $1,777,000 | +72.0% | 19,048 | +97.3% | 0.01% | +50.0% |
| Q1 2021 | $1,033,000 | +164.9% | 9,653 | +116.0% | 0.00% | +300.0% |
| Q4 2020 | $390,000 | +23.0% | 4,469 | -2.8% | 0.00% | -50.0% |
| Q3 2020 | $317,000 | – | 4,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |